Nanopublication

< Home

ID

http://purl.org/np/RA9DQQ9Pa1-xb-BC5UDNylYFuKbrDi5ZfO5OAuEFYYWYk

Formats

.trig | .trig.txt | .jelly | .jelly.txt

Content

@prefix this: <http://purl.org/np/RA9DQQ9Pa1-xb-BC5UDNylYFuKbrDi5ZfO5OAuEFYYWYk> .
@prefix sub: <http://purl.org/np/RA9DQQ9Pa1-xb-BC5UDNylYFuKbrDi5ZfO5OAuEFYYWYk#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:wdxnfuun&rows=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo .
}

sub:assertion {
  <https://uts.nlm.nih.gov/uts/umls/concept/C0011777> ns1:give <https://uts.nlm.nih.gov/uts/umls/concept/C0332183> .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-12-16T19:56:10.970666"^^xsd:dateTime;
    prov:wasGeneratedBy "S&T TWOC project version 2" .
  
  sub:version prov:value "2"^^xsd:integer .
  
  rdf:OBJECT rdfs:label "more frequently" .
  
  rdf:OBJECT-POSITION rdfs:label "437"^^xsd:integer .
  
  rdf:PREDICATE rdfs:label "given" .
  
  rdf:PREDICATE-POSITION rdfs:label "[426]" .
  
  rdf:SUBJECT rdfs:label "dexamethasone ( DEX )" .
  
  rdf:SUBJECT-POSITION rdfs:label "-1"^^xsd:integer .
  
  rdfs:ABSTRACT-UID ns3:50 "wdxnfuun" .
  
  rdfs:SENTENCE rdfs:label "Finally, simulations were performed to predict the antitumor efficacy of dexamethasone (DEX) combined with dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) under various dose regimens, where changing dosing frequency of dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) had little effect, while the antitumor efficacy of DEX combined with SUL was predicted to be improved when dexamethasone (DEX) was given more frequently." .
  
  rdfs:TRIPLE-UID ns2:wdxnfuun-TRIPLE-ABSTRACT-20 "wdxnfuun-TRIPLE-ABSTRACT-20" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C0011777> rdfs:label "dexamethasone" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C0332183> rdfs:label "frequently" .
}

sub:pubInfo {
  sub:assertion prov:wasDerivedFrom <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470835/> .
  
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "Lu1D0xocAfn/Yc96RkF34YeZg8HpDPl/2jF2tGc2RFw5eR3+QjOLpFZ1EVqVzfo0CIieqfaeYlL4EGGZ/a9dZth7oGhe47elky+QGK5oItiqkz264GAgD8l+KKH1YevcGGspoHg0xemaZaE4jHp75oTj4jW6e48bAMPbI1i2bJo=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-12-16T19:56:10.970666"^^xsd:dateTime;
    prov:wasAttributedTo <https://orcid.org/0000-0002-8954-0470> .
}